Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.48 |
| ▸ | CA1 | P00915 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CA3 | P07451 | 2/20 | 0.32 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2003827 | 0.97 | CA2 (0.46) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| SCHEMBL1617168 | 0.97 | CA2 (0.46) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| SCHEMBL1618312 | 0.97 | CA2 (0.46) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| SCHEMBL30197064 | 0.97 | CA2 (0.46) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| Phosphine SCHEMBL2053857 | 0.97 | CA2 (0.46) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| Lithium SCHEMBL30020591 | 0.97 | CA2 (0.46) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| Ammonia Solution, Strong SCHEMBL2053881 | 0.97 | CA2 (0.46) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| Tetramethylammonium Ion SCHEMBL14953647 | 0.91 | CA2 (0.41) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| SCHEMBL1618468 | 0.85 | CA2 (0.40) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| SCHEMBL6858552 | 0.84 | CA2 (0.35) | CA2CA1SMN1; SMN2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 492 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250112280-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | Westlake University (CN) | 2025-04-03 | — | — | US | claimed |
| CN-119495793-A | Non-negative electrode lithium metal battery and preparation method and application thereof | 西湖大学 | 2025-02-21 | — | — | CN | claimed |
| WO-2025036379-A1 | ANODE-FREE LITHIUM METAL BATTERY, MANUFACTURING METHOD THEREFOR AND USE THEREOF | 西湖大学 | 2025-02-20 | — | — | WO | claimed |
| CN-119447413-A | Non-negative electrode lithium metal battery and preparation method and application thereof | 西湖大学 | 2025-02-14 | — | — | CN | claimed |
| WO-2025026128-A1 | NEGATIVE ELECTRODE-FREE LITHIUM METAL BATTERY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 西湖大学 | 2025-02-06 | — | — | WO | claimed |
| EP-4471923-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | Westlake University (CN) | 2024-12-04 | — | — | EP | claimed |
| US-20240291020-A1 | COMPOSITE MATERIAL COMPRISING A FLUORINATED AMIDE AND USES THEREOF IN ELECTROCHEMICAL CELLS | HYDRO-QUéBEC (CA) | 2024-08-29 | — | — | US | claimed |
| EP-4356468-A1 | COMPOSITE MATERIAL COMPRISING A FLUORINATED AMIDE AND USES THEREOF IN ELECTROCHEMICAL CELLS | Hydro-Québec (CA) | 2024-04-24 | — | — | EP | claimed |
| CN-117625109-A | Adhesive composition comprising polyurethane and cationic dopant | 伊英克公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117501498-A | Composite materials comprising fluorinated amides and their use in electrochemical cells | 魁北克电力公司 | 2024-02-02 | — | — | CN | claimed |
| EP-1556390-A4 | FUNCTIONALIZED IONIC LIQUIDS, AND METHODS OF USE THEREOF | UNIV SOUTH ALABAMA (US) | 2007-12-26 | — | — | EP | claimed |
| US-7208605-B2 | Functionalized ionic liquids, and methods of use thereof | UNIVERSITY OF SOUTH ALABAMA (US) | 2007-04-24 | — | — | US | claimed |
| US-20060287521-A1 | Boronium-ion-based ionic liquids and methods of use thereof | UNIVERSITY OF SOUTH ALABAMA (US) | 2006-12-21 | — | — | US | claimed |
| WO-2006125175-A2 | BORONIUM-ION-BASED IONIC LIQUIDS AND METHODS OF USE THEREOF | UNIVERSITY OF SOUTH ALABAMA (US) | 2006-11-23 | — | — | WO | claimed |
| US-20060057465-A1 | Composite polymer electrolyte composition | TREKION CO., LTD. (JP) | 2006-03-16 | — | — | US | claimed |
| EP-1612809-A1 | COMPOSITE POLYMER ELECTROLYTE COMPOSITION | Trekion Co. Ltd. (JP) | 2006-01-04 | — | — | EP | claimed |
| EP-1556390-A2 | FUNCTIONALIZED IONIC LIQUIDS, AND METHODS OF USE THEREOF | University Of South Alabama (US) | 2005-07-27 | — | — | EP | claimed |
| JP-2005521750-A | — | — | 2005-07-21 | — | — | JP | claimed |
| US-20040035293-A1 | Functionalized ionic liquids, and methods of use thereof | UNIVERSITY OF SOUTH ALABAMA | 2004-02-26 | — | — | US | claimed |
| WO-2003086605-A2 | FUNCTIONALIZED IONIC LIQUIDS, AND METHODS OF USE THEREOF | UNIVERSITY OF SOUTH ALABAMA (US) | 2003-10-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250112280-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | HCN2, SLC9A5, SLC9B2 | CA2 127/4885CA1 108/4885SMN1; SMN2 454/4885 |
| US-20040035293-A1 | Functionalized ionic liquids, and methods of use thereof | TST, SCLY, MPST | CA2 150/4885CA1 72/4885SMN1; SMN2 1737/4885 |
| US-20060287521-A1 | Boronium-ion-based ionic liquids and methods of use thereof | IPO4, SLC9B2, INF2 | CA2 274/4885CA1 1017/4885SMN1; SMN2 1445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.